BioInvent International Revenue vs. Operating Margin
| BINV Stock | SEK 44.60 1.10 2.41% |
For BioInvent International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioInvent International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioInvent International AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioInvent International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioInvent International AB over time as well as its relative position and ranking within its peers.
BioInvent |
BioInvent International Operating Margin vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioInvent International's current stock value. Our valuation model uses many indicators to compare BioInvent International value to that of its competitors to determine the firm's financial worth. BioInvent International AB is rated second in revenue category among its peers. It also is rated second in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioInvent International's earnings, one of the primary drivers of an investment's value.BioInvent Revenue vs. Competition
BioInvent International AB is rated second in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 302.68 Million. BioInvent International holds roughly 19.38 Million in revenue claiming about 6% of equities under Health Care industry.
BioInvent Operating Margin vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
BioInvent International |
| = | 19.38 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
BioInvent International |
| = | (0.16) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
BioInvent Operating Margin Comparison
BioInvent International is currently under evaluation in operating margin category among its peers.
BioInvent International Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioInvent International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioInvent International will eventually generate negative long term returns. The profitability progress is the general direction of BioInvent International's change in net profit over the period of time. It can combine multiple indicators of BioInvent International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.
BioInvent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioInvent International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioInvent International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioInvent International's important profitability drivers and their relationship over time.
Use BioInvent International in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioInvent International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioInvent International will appreciate offsetting losses from the drop in the long position's value.BioInvent International Pair Trading
BioInvent International AB Pair Trading Analysis
The ability to find closely correlated positions to BioInvent International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioInvent International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioInvent International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioInvent International AB to buy it.
The correlation of BioInvent International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioInvent International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioInvent International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioInvent International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioInvent International position
In addition to having BioInvent International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Artificial Intelligence Thematic Idea Now
Artificial Intelligence
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.